Dansey Roger D
Officer at Seagen Inc.
- Sold, on record
- $35.6M
- Dollars the filings state
- Form 4 sales
- 37
- Latest Sep 21, 2023
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Seagen Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Seagen Inc.RoutineApr 17, 2023 2023
Sold 10,000 shares at $205.95 ($2.1M)
Dansey Roger D, President, R&D & CMO
10b5-1 planSold 9.1% of holdings ($22.5M position)99,389 shares left1.2x usual sizeFiling
- 2 Form 144 notice Seagen Inc.NoticeAug 16, 2023 +121 days
Filed to sell 10,122 shares ($2M)
Dansey Roger D, Officer
10b5-1 plan1.5x usual sizeFiling
- 3 Form 144 notice Seagen Inc.NoticeAug 29, 2023 +13 days
Filed to sell 1,016 shares ($209k)
Dansey Roger D, Officer
10b5-1 plan0.1x usual sizeFiling
- 4 Form 4 sale Seagen Inc.No planAug 29, 2023 same day
Sold 1,016 shares at $206.00 ($209k)
Dansey Roger D, President, R&D & CMO
No 10b5-1 planSold 0.9% of holdings ($24.1M position)115,797 shares left0.1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice Seagen Inc.NoticeAug 31, 2023 +2 days
Filed to sell 4,029 shares ($834k)
Dansey Roger D, Officer
10b5-1 plan0.6x usual sizeFiling
- 6 Form 4 sale Seagen Inc.No planAug 31, 2023 same day
Sold 4,029 shares at $206.97 ($834k)
Dansey Roger D, President, R&D & CMO
No 10b5-1 planSold 3.5% of holdings ($24M position)111,768 shares left0.6x usual sizeFollows a Form 144Filing
- 7 Form 144 notice Seagen Inc.NoticeSep 21, 2023 +21 days
Filed to sell 71 shares ($15k)
Dansey Roger D, Officer
10b5-1 plan0x usual sizeFiling
- 8 Form 4 sale Seagen Inc.No planSep 21, 2023 same day
Sold 71 shares at $206.50 ($15k)
Dansey Roger D, President, R&D & CMO
No 10b5-1 planSold 0.1% of holdings ($24.1M position)116,677 shares left0x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (42)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2023 | Sep 22, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 71 | $15k | 0.1% | No plan | SEC |
| Sep 21, 2023 | Sep 21, 2023 | Seagen Inc. | Officer | Form 144 notice | 71 | $15k | Notice | SEC | |
| Aug 31, 2023 | Sep 1, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 4,029 | $834k | 3.5% | No plan | SEC |
| Aug 31, 2023 | Aug 31, 2023 | Seagen Inc. | Officer | Form 144 notice | 4,029 | $834k | Notice | SEC | |
| Aug 29, 2023 | Aug 30, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 1,016 | $209k | 0.9% | No plan | SEC |
| Aug 29, 2023 | Aug 29, 2023 | Seagen Inc. | Officer | Form 144 notice | 1,016 | $209k | Notice | SEC | |
| Aug 16, 2023 | Aug 16, 2023 | Seagen Inc. | Officer | Form 144 notice | 10,122 | $2M | Notice | SEC | |
| Apr 17, 2023 | Apr 19, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 10,000 | $2.1M | 9.1% | Routine | SEC |
| Apr 17, 2023 | Apr 17, 2023 | Seagen Inc. | Officer | Form 144 notice | 10,000 | $2.1M | Notice | SEC | |
| Apr 6, 2023 | Apr 7, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 333 | $69k | 0.3% | No plan | SEC |
| Mar 15, 2023 | Mar 17, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 10,000 | $2M | 9.4% | Plan not stated | SEC |
| Feb 15, 2023 | Feb 17, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 10,000 | $1.4M | 9.4% | Plan not stated | SEC |
| Feb 2, 2023 | Feb 3, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 783 | $108k | 0.8% | Plan not stated | SEC |
| Jan 24, 2023 | Jan 26, 2023 | Seagen Inc. | President, R&D & CMO | Form 4 sale | 10,000 | $1.4M | 9.3% | Plan not stated | SEC |
| Jan 5, 2023 | Jan 6, 2023 | Seagen Inc. | President R&D & CMO | Form 4 sale | 10,000 | $1.4M | 9.3% | Plan not stated | SEC |
| Dec 14, 2022 | Dec 16, 2022 | Seagen Inc. | President, Research and Develo | Form 4 sale | 10,000 | $1.4M | 9.3% | Plan not stated | SEC |
| Oct 17, 2022 | Oct 19, 2022 | Seagen Inc. | Interim CEO & CMO | Form 4 sale | 10,000 | $1.4M | 9.3% | Plan not stated | SEC |
| Aug 31, 2022 | Sep 1, 2022 | Seagen Inc. | Interim CEO & CMO | Form 4 sale | 5,019 | $775k | 4.9% | Plan not stated | SEC |
| Aug 16, 2022 | Aug 17, 2022 | Seagen Inc. | Interim CEO & CMO | Form 4 sale | 4,254 | $724k | 4.0% | Plan not stated | SEC |
| Jun 28, 2022 | Jun 30, 2022 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 34,635 | $6.2M | 35.8% | Unusual | SEC |
| Apr 21, 2022 | Apr 22, 2022 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 1,439 | $208k | 1.8% | Plan not stated | SEC |
| Feb 3, 2022 | Feb 4, 2022 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 1,442 | $197k | 1.8% | Plan not stated | SEC |
| Jan 3, 2022 | Jan 5, 2022 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 8,675 | $1.3M | 9.8% | Plan not stated | SEC |
| Dec 21, 2021 | Dec 22, 2021 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 560 | $86k | 0.6% | Plan not stated | SEC |
| Aug 31, 2021 | Sep 2, 2021 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 4,611 | $772k | 5.1% | Plan not stated | SEC |
| Aug 16, 2021 | Aug 18, 2021 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 1,657 | $256k | 2.2% | Plan not stated | SEC |
| Aug 13, 2021 | Aug 13, 2021 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 10,000 | $1.6M | 11.8% | Plan not stated | SEC |
| Jun 16, 2021 | Jun 21, 2021 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 25,109 | $3.8M | 22.9% | Unusual | SEC |
| Nov 4, 2020 | Nov 5, 2020 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 7,661 | $1.4M | 6.5% | Plan not stated | SEC |
| Aug 31, 2020 | Sep 2, 2020 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 4,611 | $718k | 3.8% | Plan not stated | SEC |
| Aug 17, 2020 | Aug 17, 2020 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 450 | $71k | 0.4% | Plan not stated | SEC |
| Jun 17, 2020 | Jun 19, 2020 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 2,162 | $344k | 1.9% | Plan not stated | SEC |
| Jun 16, 2020 | Jun 17, 2020 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 5,822 | $915k | 5.0% | Plan not stated | SEC |
| May 7, 2020 | May 8, 2020 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 11,912 | $2M | 9.2% | Unusual | SEC |
| Feb 18, 2020 | Feb 20, 2020 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 350 | $41k | 0.3% | Plan not stated | SEC |
| Feb 3, 2020 | Feb 5, 2020 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 727 | $79k | 0.7% | Plan not stated | SEC |
| Dec 16, 2019 | Dec 17, 2019 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 2,000 | $228k | 1.9% | Plan not stated | SEC |
| Nov 25, 2019 | Nov 27, 2019 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 5,000 | $607k | 4.6% | Plan not stated | SEC |
| Nov 18, 2019 | Nov 20, 2019 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 5,000 | $580k | 4.6% | Plan not stated | SEC |
| Sep 25, 2019 | Sep 27, 2019 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 3,000 | $221k | 2.8% | Plan not stated | SEC |
| Sep 3, 2019 | Sep 4, 2019 | Seagen Inc. | Officer | Form 4 sale | 922 | $65k | 0.9% | Plan not stated | SEC |
| Jun 17, 2019 | Jun 19, 2019 | Seagen Inc. | Chief Medical Officer | Form 4 sale | 5,416 | $372k | 6.5% | Plan not stated | SEC |